Literature DB >> 1449178

Cochlear implants in the management of bilateral acoustic neuromas.

R A Hoffman1, D Kohan, N L Cohen.   

Abstract

Multichannel cochlear implants currently provide the only modality for successful auditory rehabilitation of patients with bilateral profound sensorineural hearing loss who derive no benefit from amplification. We have developed a protocol for patients with neurofibromatosis and bilateral acoustic neuromas in which every effort is made to preserve hearing in at least one ear. Failing that, the cochlear nerve is spared, potentially allowing for the insertion of a cochlear implant. We present our data on one such patient whose auditory function was restored with a Nucleus mini 22-channel cochlear implant following removal of his acoustic neuroma.

Entities:  

Mesh:

Year:  1992        PMID: 1449178

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  17 in total

Review 1.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

2.  Decision making in acoustic neuroma management: the only hearing ear.

Authors:  M B Naguib; E Saleh; M Aristegui; A Mazzoni; M Sanna
Journal:  Skull Base Surg       Date:  1994

Review 3.  [Magnetic resonance imaging in patients with magnetic hearing implants: overview and procedural management].

Authors:  S Nospes; W Mann; A Keilmann
Journal:  Radiologe       Date:  2013-11       Impact factor: 0.635

4.  Cochlear obliteration after translabyrinthine vestibular schwannoma surgery.

Authors:  Caroline Beutner; Christian Mathys; Bernd Turowski; Jörg Schipper; Thomas Klenzner
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-11       Impact factor: 2.503

5.  Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.

Authors:  Pamela C Roehm; Jon Mallen-St Clair; Daniel Jethanamest; John G Golfinos; William Shapiro; Susan Waltzman; J Thomas Roland
Journal:  J Neurosurg       Date:  2011-07-15       Impact factor: 5.115

6.  Cochlear Patency after Translabyrinthine and Retrosigmoid Vestibular Schwannoma Surgery.

Authors:  Huibert Frans van Waegeningh; Elke Loos; Tony Van Havenbergh; Thomas Somers
Journal:  J Int Adv Otol       Date:  2020-04       Impact factor: 1.017

7.  Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best hearing ear and in patients with NF2.

Authors:  Luis Lassaletta; Miguel Aristegui; Marimar Medina; Gracia Aranguez; Rosa M Pérez-Mora; Maurizio Falcioni; Javier Gavilán; Paolo Piazza; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-24       Impact factor: 2.503

8.  CNAP To Predict Functional Cochlear Nerve Preservation in NF-2: Cochlear Implant or Auditory Brainstem Implant.

Authors:  Enrico Piccirillo; Maurizio Guida; Sean Flanagan; Lorenzo Lauda; Paolo Fois; Mario Sanna
Journal:  Skull Base       Date:  2008-07

9.  Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.

Authors:  Haoyue Tan; Huan Jia; Yun Li; Zhihua Zhang; Weidong Zhu; Yun Cai; Zhaoyan Wang; Hao Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-18       Impact factor: 2.503

10.  Stereotactic radiosurgery does not appear to impact cochlear implant performance in patients with neurofibromatosis type II.

Authors:  Justyn Pisa; Jacob Sulkers; James B Butler; Michael West; Jordan B Hochman
Journal:  J Radiosurg SBRT       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.